T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.
Kai-Rong LinFei-Wen DengYa-Bin JinXiang-Ping ChenYing-Ming PanJin-Huan CuiZhi-Xuan YouHuan-Wei ChenWei LuoPublished in: Cancer medicine (2018)
Tumor-infiltrating T cell repertoire has been demonstrated to be closely associated with anti-tumor immune response. However, the relationship between T cell repertoire in tumor tissue and prognosis has never been reported in Hepatocellular carcinoma (HCC). We performed the high-throughput T cell receptor (TCR) sequencing to systematically characterize the infiltrating T cell repertoires of tumor and matched adjacent normal tissues from 23 HBV-associated HCC patients. Significant differences on usage frequencies of some Vβ, Jβ, and Vβ-Jβ paired genes have been found between the 2 groups of tissue samples, but no significant difference of TCR repertoire diversity could be found. Interestingly, the similarity of TCR repertoires between paired samples or the TNM stage alone could not be helpful to evaluate the prognosis of patients very well, but their combination could serve as an efficient prognostic indicator that the patients with early stage and high similarity showed a better prognosis. This is the first attempt to assess the potential value of TCR repertoire in HCC prognosis, and our findings could serve as a complement for the characterization of TCR repertoire in HCC.
Keyphrases
- regulatory t cells
- early stage
- immune response
- high throughput
- end stage renal disease
- newly diagnosed
- ejection fraction
- high throughput sequencing
- hepatitis b virus
- single cell
- gene expression
- prognostic factors
- radiation therapy
- risk assessment
- genome wide
- neoadjuvant chemotherapy
- dna methylation
- locally advanced
- liver failure
- binding protein
- human health
- sentinel lymph node